Kyle Grant

Kyle Grant

Company: Voyager Therapeutics

Job title: Director of Vector Production


Determining if Improved Impurification Techniques Can Impact Potency 9:15 am

Assess the impact of commercial purification techniques on a drug substance purity and potency in vitro and in vivo. Evaluate the impact and influence of viral delivery on clinical safety. Assess the current purification techniques and the advantages of novel methodologies.Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.